Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Court: Drugmaker can be held responsible for generic-label omission
The Alabama Supreme Court ruled Pfizer can be held liable for safety information omitted from a generic version of its Reglan heartburn drug, writing that omissions or other problems with brand-name drug labels "would necessarily be repeated" on corresponding generic drug labels.
Or we can send an email on your behalf